The Effect of Repeated Whole-body NMES Sessions With or Without Protein Intake on Muscle Protein Synthesis During 3 Days of Bed Rest in Healthy Young Volunteers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorWageningen University

About this trial

The goal of this clinical trial is to examine the effect of whole-body electrostimulation with protein intake on muscle protein synthesis, muscle mass and function during bed rest in healthy young adults (18-35 years). The main questions to answer are:

* Does whole-body NMES followed by protein intake improve muscle protein synthesis rates during 3 days of bed rest? * Does repeated NMES sessions offer protective effects on muscle mass and function during extended periods of inactivity?

Researchers will compare sham electrical electrostimulation, electrical stimulation and electrical stimulation + protein groups to see if whole-body electrostimulation combined with protein intake offers the greatest improvement in muscle protein metabolism and muscle preservation.

Participants will:

* Undergo 3 days of bed rest while receiving one of the following interventions:

* Sham-NMES followed by standard nutrition (CON) * Whole-body NMES followed by standard nutrition(NMES) * Whole-body NMES followed by a bolus of 20g protein (NMES+PRO) * Receive heavy water (D2O) to assess body water turnover. * Undergo leg extension exercises to assess muscle function. * Have quadriceps muscle thickness measured via ultrasound. * Provide saliva samples for analysis. * Have calf circumference measured to monitor changes in muscle mass.

Eligibility criteria

Qualifiers

Aged from 18-35 years

18.5 < BMI < 30 kg·m2

Recreationally active (performing non-competitive physical exercise at least one time per week for minimally 30 minutes)

Disqualifiers

Employed or undertaking a thesis or internship at the department of Human and Animal Physiology at Wageningen University

Smoking

Diabetes (Type 1, Type 2, or genetic form of diabetes)

Any diagnosed cardiovascular (heart) disease or high blood pressure (≥140 mmHg systolic and/or

Trial design

Treatments tested in this trial

  • Sham (No Treatment)
  • NMES
  • Protein bolus (20g)
  • Standard nutrition

Treatment groups

42 Participants
are divided into 3 treatment groups

Sponsors and collaborators